Cargando…
No evidence that plasmablasts transdifferentiate into developing neutrophils in severe COVID‐19 disease
OBJECTIVES: A recent single‐cell RNA sequencing study by Wilk et al. suggested that plasmablasts can transdifferentiate into ‘developing neutrophils’ in patients with severe COVID‐19 disease. We explore the evidence for this. METHODS: We downloaded the original data and code used by the authors in t...
Autores principales: | Alquicira‐Hernandez, José, Powell, Joseph E, Phan, Tri Giang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245277/ https://www.ncbi.nlm.nih.gov/pubmed/34221402 http://dx.doi.org/10.1002/cti2.1308 |
Ejemplares similares
-
The signal pathway for the repressive effect of dipyridamole on myofibroblast transdifferentiation
por: Yan, Qiong, et al.
Publicado: (2018) -
Plasmablastic lymphoma in Malawi
por: Zuze, Takondwa, et al.
Publicado: (2018) -
Clinical Features of Plasmablastic Lymphoma: Case Series From an Asian Tertiary Cancer Center and Literature Review
por: Yap, Daniel Ren Yi, et al.
Publicado: (2020) -
Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients
por: Haghjooy Javanmard, Shaghayegh, et al.
Publicado: (2020) -
Under inflammatory stimuli mesenteric mesothelial cells transdifferentiate into macrophages and produce pro-inflammatory cytokine IL-6
por: Katz, Sándor, et al.
Publicado: (2019)